新股消息 | 迈瑞医疗(300760.SZ)递表港交所

Group 1 - The core viewpoint of the article highlights that Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray Medical) has submitted an application to list on the Hong Kong Stock Exchange, with Huatai International and JPMorgan as joint sponsors [1] - Mindray Medical is recognized as a leading, innovation-driven global medical device company and a leader in medical digitization [1] - According to Frost & Sullivan, by 2024, Mindray Medical's market value in the Chinese medical device industry will exceed the combined value of the second to fifth largest domestic competitors, with industrial revenue more than double that of the second-largest competitor [1] Group 2 - Mindray Medical ranks 23rd among the top global medical device companies and is the only Chinese company in the top 30, achieving this status faster than any other company since its establishment [1] - The company has established a comprehensive product matrix covering multiple products and production lines, making it the only top global medical device company that spans various clinical scenarios from emergency, operating room, intensive care unit, to general wards, and across multiple specialties [1] - By 2024, Mindray Medical is expected to lead in multiple fields, with six product categories ranked among the top three globally and nine product categories holding the number one market share in China [1]